FDA 483 - Rinovum Subsidiary 2 LLC - June 11, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Rinovum Women's Health in Monroeville, PA, received a Form FDA 483 following an inspection of their medical device specification development. The inspection revealed significant deficiencies in complaint handling, corrective and preventive actions, and risk analysis for their Stork OTC device. Specifically, the firm failed to adequately investigate complaints, particularly those involving cervical cap separation requiring medical intervention, and had inadequate CAPA procedures and risk assessments for these recurring issues.
ID · ade5b6b9-fc06-44be-8787-5d099fe7e528